MR编号 | DE/H/0722/003 |
---|
药品名称 | XEOMIN 200 Einheiten Pulver zur Herstellung einer Injektionslösung |
---|
活性成分 | - Clostridium botulinum type A neurotoxin complex 200.0 LD50 units
|
---|
剂型 | Powder for solution for injection |
---|
上市许可持有人 | Merz Pharmaceuticals GmbH
Eckenheimer Landstr. 100
60318 Frankfurt am Main
Germany |
---|
参考成员国 - 产品名称 | Germany (DE) Xeomin |
---|
互认成员国 - 产品名称 | - Denmark (DK)
- Belgium (BE)
XEOMEEN 200 unités poudre pour solution injectable - Netherlands (NL)
- Luxembourg (LU)
- Iceland (IS)
- Ireland (IE)
- Liechtenstein (LI)
- Austria (AT)
- France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
XEOMIN - Sweden (SE)
- Norway (NO)
Xeomin - Finland (FI)
- Poland (PL)
Xeomin - Latvia (LV)
Xeomin 200 V pulveris injekciju šķīduma pagatavošanai - Lithuania (LT)
XEOMIN 200 V milteliai injekciniam tirpalui - Estonia (EE)
- Hungary (HU)
XEOMIN 200 egység por oldatos injekcióhoz - Bulgaria (BG)
XEOMIN - Cyprus (CY)
- Czechia (CZ)
XEOMIN 200 jednotek prášek pro injekční roztok - Romania (RO)
XEOMIN 200 unităţi pulbere pentru soluţie injectabilă - Slovakia (SK)
XEOMIN 200 LD50 jednotiek prášok na injekčný roztok - Slovenia (SI)
- Malta (MT)
XEOMIN 200 LD50 units powder for solution for injection - Croatia (HR)
|
---|
许可日期 | 2016/04/05 |
---|
最近更新日期 | 2024/12/09 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|